Format

Send to

Choose Destination
PLoS One. 2016 May 9;11(5):e0155095. doi: 10.1371/journal.pone.0155095. eCollection 2016.

Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.

Author information

1
Department of Gastroenterology, Huizhou First Hospital, Huizhou, 516003, China.
2
Department of Gastroenterology, Hainan provincial people's Hospital, Haikuo, 570100, China.
3
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
4
Huizhou Medicine Institute, Huizhou First Hospital, Huizhou, 516003, China.
5
School of Public Health, Kunming Medical University, Kunming, 650500, China.

Abstract

DNA hypermethylation in blood is becoming an attractive candidate marker for colorectal cancer (CRC) detection. To assess the diagnostic accuracy of blood hypermethylation markers for CRC in different clinical settings, we conducted a meta-analysis of published reports. Of 485 publications obtained in the initial literature search, 39 studies were included in the meta-analysis. Hypermethylation markers in peripheral blood showed a high degree of accuracy for the detection of CRC. The summary sensitivity was 0.62 [95% confidence interval (CI), 0.56-0.67] and specificity was 0.91 (95% CI, 0.89-0.93). Subgroup analysis showed significantly greater sensitivity for the methylated Septin 9 gene (SEPT9) subgroup (0.75; 95% CI, 0.67-0.81) than for the non-methylated SEPT9 subgroup (0.58; 95% CI, 0.52-0.64). Sensitivity and specificity were not affected significantly by target gene number, CRC staging, study region, or methylation analysis method. These findings show that hypermethylation markers in blood are highly sensitive and specific for CRC detection, with methylated SEPT9 being particularly robust. The diagnostic performance of hypermethylation markers, which have varied across different studies, can be improved by marker optimization. Future research should examine variation in diagnostic accuracy according to non-neoplastic factors.

PMID:
27158984
PMCID:
PMC4861294
DOI:
10.1371/journal.pone.0155095
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center